A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE

$6,078P41FY2010RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 37817282 Paper 37409680 Paper 36001419 Paper 34368492 Paper 34136937 Paper 33479453 Paper 33197798 Paper 32980206 Paper 32860348 Paper 32795248 Paper 31931515 Paper 31230465 Paper 31200127 Paper 30694611 Paper 29201279 Paper 29152411 Paper 29029214 Paper 28284787 Paper 28262939 Paper 27990494 Paper 27896947 Paper 27766650 Paper 27637394 Paper 27566120 Paper 27343889 Paper 27217502 Paper 26925198 Paper 26909326 Paper 26877833 Paper 26770662 Paper 26753181 Paper 26637429 Paper 26444770 Paper 26401777 Paper 26250048 Paper 26228398 Paper 26213720 Paper 26061819 Paper 26017779 Paper 26005673 Paper 25947071 Paper 25940587 Paper 25934168 Paper 25821147 Paper 25752642 Paper 25676553 Paper 25580444 Paper 25555505 Paper 25404992 Paper 25392563 Paper 25282602 Paper 25242858 Paper 25203512 Paper 25144603 Paper 25137219 Paper 25106071 Paper 25072390 Paper 24997672 Paper 24827471 Paper 24778373 Paper 24771276 Paper 24721821 Paper 24683971 Paper 24634832 Paper 24581503 Paper 24576106 Paper 24562737 Paper 24497750 Paper 24486438 Paper 24473096 Paper 24465054 Paper 24416245 Paper 24357915 Paper 24295552 Paper 24179807 Paper 24179761 Paper 24148888 Paper 24113873 Paper 24092494 Paper 24040118 Paper 24033579 Paper 24032982 Paper 23982962 Paper 23938313 Paper 23880040 Paper 23836455 Paper 23813738 Paper 23811412 Paper 23785658 Paper 23769413 Paper 23727529 Paper 23724358 Paper 23722009 Paper 23694947 Paper 23616547 Paper 23583670 Paper 23582873 Paper 23532891 Paper 23503649 Paper 23461767

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. "A combination trial of copaxone plus estriol in relapsing remitting multiple sclerosis" A multicenter double blind placebo controlled trial to determine if oral estriol treatment is effective in decreasing disease activity in women with relapsing remitting multiple sclerosis as measured by relapse rate, imaging and immunological markers.

View original record on NIH RePORTER →